Peripheral access size evaluation in transfemoral transcatheter aortic valve replacement.
Irbaz HameedChristian T OakleyN U F HameedYuan JiangNyla NaeemMahmoud MorsiAdham AhmedAndrea AmabileSameer A HirjiQuynh A TruongMario F L GaudinoTsuyoshi KanekoArash SalemiPublished in: Journal of cardiac surgery (2022)
Most patients screened for TAVR have minimum peripheral access vessel sizes exceeding the recommended minimum access route diameters of modern transcatheter heart valves. As sheath sizes decrease, clinicians must carefully judge patient individual risk factors to determine whether a pre-TAVR CTA assessing peripheral access vessel dimensions and anatomical contraindications is indicated. Larger studies and randomized controlled trials are required to compare the outcomes of TAVR with and without preoperative CTA.
Keyphrases
- transcatheter aortic valve replacement
- aortic valve
- aortic stenosis
- aortic valve replacement
- ejection fraction
- transcatheter aortic valve implantation
- risk factors
- end stage renal disease
- randomized controlled trial
- newly diagnosed
- chemotherapy induced
- chronic kidney disease
- peritoneal dialysis
- heart failure
- patients undergoing
- clinical trial
- systematic review
- atrial fibrillation
- left ventricular
- skeletal muscle
- double blind